Premature ovarian insufficiency

Female childhood, adolescent and young adult cancer survivors treated with alkylating agent chemotherapy and/or radiation potentially exposing the ovaries have an increased risk of premature ovarian insufficiency. Because of this high risk survivors may benefit from surveillance.

Premature ovarian insufficiency surveillance recommendations

We are currently updating the evidence and recommendations.